Ovid Therapeutics Inc.
- OVID
- NASDAQ
- Biotechnology
- Neurology Biotech
- Neurological Disease Therapeutics
$2.15
Today −4.87%Quote Oct 16, 2026, 08:00 PM UTC
−20.37%over the last month
Max drawdown −22.1%From 1-month high −22.1%3 months −6.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$419.9M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$6.25
+190.7% from here
Floor
$2.12
1.5% below price
Where the price sits
14 analysts
Analyst range, low to high
$5.00$8.00
- Price $2.15
- Resistance $2.19
- Consensus $6.25
The price is just above its floor and right under resistance. Analysts' average target sits about 191% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about OVIDPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
23